Development of atherosclerosis and infectious agents.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Internal medicine

• Publication date

  2003-07-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.2169/INTERNALMEDICINE.42.547PMID 12879941
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Statin Therapy Interacts With Cytomegalovirus Seropositivity and High C-Reactive Protein in Reducing Mortality Among Patients With Angiographically Significant Coronary Disease

  2003cited by this paper
• Infectious serology and atherosclerosis: how burdensome is the risk?

  2003cited by this paper
• Chlamydial LPS antibodies, intima-media thickness and ischemic events in patients with established atherosclerosis.

  2003cited by this paper
• Multiple Infections and Subsequent Cardiovascular Events in the Heart Outcomes Prevention Evaluation (HOPE) Study

  2003cited by this paper
• An association between an antibody against Chlamydia pneumoniae and ischemic stroke in elderly Japanese.

  2003cited by this paper
• Predisposition to Atherosclerosis by Infections: Role of Endothelial Dysfunction

  2002cited by this paper
• Lack of Association Between Serum Immunoreactivity and Chlamydia pneumoniae Detection in the Human Aortic Wall

  2002cited by this paper
• Increased Circulating Immune Complexes in Acute Stroke: The Triggering Role of Chlamydia pneumoniae and Cytomegalovirus

  2002cited by this paper
• Chronic Infections and the Risk of Carotid Atherosclerosis Prospective Results From a Large Population Study

  2001cited by this paper
• Chronic Infections and the Risk of Carotid Atherosclerosis: Prospective Results From a Large Population Study

  2001cited by this paper
• Impact of Viral and Bacterial Infectious Burden on Long-Term Prognosis in Patients With Coronary Artery Disease

  2001cited by this paper
• Chlamydia pneumoniae in Atherosclerotic Middle Cerebral Artery

  2001cited by this paper
• Association Between Infection With Helicobacter pylori and Chlamydia pneumoniae and Risk of Ischemic Stroke Subtypes: Results From a Population-Based Case-Control Study

  2001cited by this paper
• Cytomegalovirus Seropositivity and C-Reactive Protein Have Independent and Combined Predictive Value for Mortality in Patients With Angiographically Demonstrated Coronary Artery Disease

  2000cited by this paper
• Chlamydia pneumoniae and the risk of first ischemic stroke : The Northern Manhattan Stroke Study.

  2000cited by this paper
• Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis.

  2000cited by this paper
• Infection and atherosclerosis: emerging mechanistic paradigms.

  1999cited by this paper
• Chlamydia pneumoniae antibodies and high lipoprotein(a) levels do not predict ischemic cerebral infarctions. Results from a nested case-control study in Northern Sweden.

  1999cited by this paper
• Atherosclerosis--an inflammatory disease.

  1999cited by this paper
• Chlamydia pneumoniae but not cytomegalovirus antibodies are associated with future risk of stroke and cardiovascular disease: a prospective study in middle-aged to elderly men with treated hypertension.

  1999cited by this paper
• C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992.

  1999cited by this paper
• Coronary heart disease, Helicobacter pylori, dental disease, Chlamydia pneumoniae, and cytomegalovirus: meta-analyses of prospective studies.

  1999cited by this paper
• Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model.

  1998cited by this paper
• Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction.

  1998cited by this paper
• Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease.

  1996cited by this paper
• Association of chlamydial infection with cerebrovascular disease.

  1996cited by this paper
• Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction.

  1982cited by this paper
• Infection of with

  1980cited by this paper

• Is there a link between atrial fibrillation and certain bacterial infections?

  2007cites this paper